Emma Smith

Researcher
DISC Type : Cs

Chief Financial Officer at Dark Blue Therapeutics

Oxford, England, United Kingdom

Overview

A strategic CFO with over a decade of experience in biotech and life sciences, specializing in VC and PE-backed ventures. Holding an MA from the University of Cambridge and an FCA qualification, they have deep expertise in fundraising, governance, and operational efficiency, guiding companies to successful growth.

Recently orchestrated the successful acquisition of Dark Blue Therapeutics by Amgen.

Personality Overview

Cost Conscious

Process Focused

ROI Seeker

They do not like taking risks at all and go for proven options in the end.  They are always well-planned and adopt a systematic approach. They are heavily focused on quality and prefer doing things the right way, even if it takes time.

Topics They Care About

Biotech Finance
Manages the full financial spectrum for life science companies, focusing on financial strategy, fundraising, and scalable operations to support innovative ventures.
Company Acquisitions
Recently demonstrated expertise by leading Dark Blue Therapeutics through a successful acquisition by Amgen, and is certified in advising on business disposals.
Venture-Backed Growth
Specializes in financial strategies for VC and private-equity-backed businesses, helping them optimize profitability, plan for growth, and secure funding.

Media Appearances

Amgen Acquires Dark Blue Therapeutics, Bolstering Oncology Pipeline. Featured in BioSpace

See Now

Work History

3-2023
Chief Financial Officer at Dark Blue Therapeutics
2-2017 - 2-2023
Fractional CFO and FD consultancy at Elsfa Limited
8-2020 - 7-2021
Interim Finance Director at Cellinta Limited
5-2019 - 2-2021
Interim Financial Controller at Macrophox Limited
9-2018 - 8-2019
Interim Head of FP&A at The Private Infrastructure Development Group

Education

2010 - 2012
Fellow of ICAEW (FCA) from ICAEW
2004 - 2007
Master of Arts (MA) from University of Cambridge

More Information

Social Presence :

Prographics :

Exp : 7 Location : Oxford, England, United Kingdom Job Level : Leadership Designation : Chief Financial Officer at Dark Blue Therapeutics
URL has been copied!

Insights For Selling To Emma

During A Call Or A Meeting

DO's

  • Preferably use email to follow up with them instead of phone or Linkedin, engage by asking question or opinions
  • Use a presentation with information before getting into a live product walkthrough
  • Use phrases like 'results based on data', 'measurable proof', 'X% growth' etc.

DONT's

  • Avoid winging it with them particularly, answer a question only if you know the answer well
  • Avoid emotional and informal language, stay objective and to the point instead
  • Give it some time before you try to build rapport and a relationship, it doesn't come to them naturally

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Emma is

  • Proof of usage by others in the industry, case studies showing ROI are likely to work the best with them.
  • Will you ever get a clear answer from Emma

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Emma move?

  • They are some of the slowest movers and take their time reaching decisions.
  • Can Emma take some risk or not?

  • They have very low acceptance of risk even if they do not say it directly.

You And Emma

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.